
CNX-1351
CAS No. 1276105-89-5
CNX-1351 ( CNX1351 | CNX 1351 | CNX-1351 )
产品货号. M17234 CAS No. 1276105-89-5
CNX-1351 是一种有效的异构体选择性靶向共价 PI3Kα 抑制剂。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥786 | 有现货 |
![]() ![]() |
10MG | ¥1256 | 有现货 |
![]() ![]() |
25MG | ¥2398 | 有现货 |
![]() ![]() |
50MG | ¥4431 | 有现货 |
![]() ![]() |
100MG | ¥6391 | 有现货 |
![]() ![]() |
500MG | ¥13203 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CNX-1351
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CNX-1351 是一种有效的异构体选择性靶向共价 PI3Kα 抑制剂。
-
产品描述CNX-1351 is a selective covalent Inhibitor of PI3Kα. In an end point assay, CNX-1351 potently inhibited PI3Kα and was 20?400 times less potent against β, γ, and δ. CNX-1351 inhibit PI3Kα signaling in cells and shows prolonged inhibition consistent with a covalent mechanism of Action. CNX-1351 inhibits growth of cells dependent on PI3Kα. CNX-1351 also inhibits PI3Kα signaling in vivo and bonds to p110α.
-
体外实验——
-
体内实验——
-
同义词CNX1351 | CNX 1351 | CNX-1351
-
通路Others
-
靶点Other Targets
-
受体PI3Kα
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number1276105-89-5
-
分子量573.71
-
分子式C30H35N7O3S
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 21.8 mg/mL. 38.00 mM
-
SMILESC1CN(CCN1C(=O)CCC(=O)C=C(C)C)Cc1cc2c(s1)c(nc(n2)c1cccc2c1cn[nH]2)N1CCOCC1
-
化学全称1-(4-((2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-6-methylhept-5-ene-1,4-dione
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Nacht M, et al. J Med Chem. 2013 Feb 14;56(3):712-21.
产品手册




关联产品
-
Beta-MSH (1-22) huma...
β-Melanocyte Stimulating Hormone (MSH), human (Synonyms: Beta-MSH (1-22) (human)) β-Melanocyte Stimulating Hormone (MSH), human, a 22-residue peptide, acts as an endogenous melanocortin-4 receptor (MC4-R) agonist.
-
Protein Kinase C (19...
Protein Kinase C (19-31) TFA, a peptide inhibitor of protein kinase C (PKC), derived from the pseudo-substrate regulatory domain of PKCa (residues 19-31) with a serine at position 25 replacing the wild-type alanine, is used as protein kinase C substrate peptide for testing the protein kinase C activity.
-
DuP 105
DuP 105 是一种口服活性恶唑烷酮,是一种新型合成抗菌剂,具有对抗革兰氏阳性菌的活性。